<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03957135</url>
  </required_header>
  <id_info>
    <org_study_id>SNUBH-GS-HBP4</org_study_id>
    <nct_id>NCT03957135</nct_id>
  </id_info>
  <brief_title>Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Cancer: a Multicenter Randomized Controlled Trial</brief_title>
  <official_title>Multicenter Prospective Randomized Controlled Clinical Trial for Comparison Between Laparoscopic and Open Distal Pancreatectomy for Ductal Adenocarcinoma of the Pancreatic Body and Tail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul St. Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      When pancreatic cancer of the body and tail is diagnosed, a distal pancreatectomy is planned.
      This operation can be performed with open surgery, or with laparoscopic surgery. This study
      is a multicenter randomized controlled trial to evaluate the operative outcomes and survival
      of open versus laparoscopic distal pancreatectomy for pancreatic cancer of the body and tail.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      * Purpose

      To compare the safety and oncologic feasibility of open versus laparoscopic distal
      pancreatectomy for the treatment of pancreatic ductal adenocarcinoma (PDAC) of the body and
      tail.

      * Study method

      Multicenter prospective randomized controlled trial Noninferiority analysis Patients
      diagnosed with PDAC of the body and tail, without evidence of distant metastasis or direct
      invasion of adjacent organs, will be randomly allocated to either the open distal
      pancreatectomy group or the laparoscopic distal pancreatectomy group. Postoperative outcomes
      and survival data will be analyzed.

      * Number of subjects

      Sample size was calculated based on 2 year survival after pancreatectomy.

      pA: 2 year survival of open distal pancreatectomy pB: 2 year survival of laparoscopic distal
      pancreatectomy

      Null hypothesis: The 2 year survival of laparoscopic distal pancreatectomy is inferior to
      that of open distal pancreatectomy. H0: pA−pB≥δ

      Alternative hypothesis: The 2 year survival of laparoscopic distal pancreatectomy is not
      inferior to that of open distal pancreatectomy. H1: pA−pB&lt;δ

      2 year survival of pancreatectomy (Shin et al, 2015) is 55.9% for open and 64.3% for
      laparoscopic distal pancreatectomy.

      When α=5%, 1-β=80%, δ=10%, and one-sided analysis is performed with a power of 80%, the
      required number of subjects is 111 for each group.

      With a drop rate of 10%, the final number of each group is 122, with a total of 244.

      * Primary and Secondary endpoints

      Primary endpoint: 2 year overall survival

      Secondary endpoint: R0 resection rate, 2 year disease free survival, 2 year recurrence rate,
      complication rate, postoperative hospital stay, operative time, estimated blood loss
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective randomized controlled clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>2 year survival</measure>
    <time_frame>2 years</time_frame>
    <description>Overall survival at 2 years after surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">244</enrollment>
  <condition>Pancreas Neoplasm Malignant Resectable</condition>
  <arm_group>
    <arm_group_label>Laparoscopic distal pancreatectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving laparoscopic distal pancreatectomy for pancreatic tail and body cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>open distal pancreatectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving open distal pancreatectomy for pancreatic tail and body cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic distal pancreatectomy</intervention_name>
    <description>Laparoscopic resection of the diseased portion of the pancreas for treatment of pancreatic cancer</description>
    <arm_group_label>Laparoscopic distal pancreatectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open distal pancreatectomy</intervention_name>
    <description>Open resection of the diseased portion of the pancreas for treatment of pancreatic cancer</description>
    <arm_group_label>open distal pancreatectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pancreatic ductal adenocarcinoma that is pathologically confirmed or shows
             characteristic radiologic features

          -  No evidence of distant metastasis

          -  No direct invasion of adjacent structures, with the exception of mesocolon or left
             adrenal gland

          -  Possible to achieve a negative margin from adjacent major vasculature (Common hepatic
             artery, superior mesenteric artery, celiac axis, superior mesenteric vein - portal
             vein)

          -  Eastern Cooperative Oncology Group (ECOG) performance score 0-2

          -  Patients with informed consent

        Exclusion Criteria:

          -  History of other malignancy (with the exception of more than 5 year interval, with no
             evidence of recurrence)

          -  Necessity of resection of other abdominal organs

          -  Recurrent pancreatic cancer

          -  Neoadjuvant chemotherapy

          -  Comorbidities with a high risk for general anesthesia

          -  Other subject whom the investigator deems inappropriate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ho-Seong Han, M.D. Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jun Suh Lee, M.D. Ph.D.</last_name>
    <phone>+82-10-2747-6320</phone>
    <email>rudestock@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yoo-Seok Yoon, M.D. Ph.D.</last_name>
    <email>arsyun@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Kyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Suh Lee, M.D., Ph.D.</last_name>
      <phone>+82-10-2747-6320</phone>
      <email>rudestock@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ho-Seong Han, M.D.,Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yoo-Seok Yoon, M.D.,Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Yoon YS, Lee KH, Han HS, Cho JY, Jang JY, Kim SW, Lee WJ, Kang CM, Park SJ, Han SS, Ahn YJ, Yu HC, Choi IS. Effects of laparoscopic versus open surgery on splenic vessel patency after spleen and splenic vessel-preserving distal pancreatectomy: a retrospective multicenter study. Surg Endosc. 2015 Mar;29(3):583-8. doi: 10.1007/s00464-014-3701-9. Epub 2014 Jul 9.</citation>
    <PMID>25005018</PMID>
  </reference>
  <reference>
    <citation>Yoon YS, Lee KH, Han HS, Cho JY, Ahn KS. Patency of splenic vessels after laparoscopic spleen and splenic vessel-preserving distal pancreatectomy. Br J Surg. 2009 Jun;96(6):633-40. doi: 10.1002/bjs.6609.</citation>
    <PMID>19434700</PMID>
  </reference>
  <reference>
    <citation>Shin SH, Kim SC, Song KB, Hwang DW, Lee JH, Lee D, Lee JW, Jun E, Park KM, Lee YJ. A comparative study of laparoscopic vs. open distal pancreatectomy for left-sided ductal adenocarcinoma: a propensity score-matched analysis. J Am Coll Surg. 2015 Feb;220(2):177-85. doi: 10.1016/j.jamcollsurg.2014.10.014. Epub 2014 Oct 31.</citation>
    <PMID>25529901</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 17, 2019</study_first_submitted>
  <study_first_submitted_qc>May 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2019</study_first_posted>
  <last_update_submitted>June 11, 2019</last_update_submitted>
  <last_update_submitted_qc>June 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Ho-Seong Han</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>pancreas neoplasms</keyword>
  <keyword>pancreatectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

